Clinical Trials Update: Oct. 12, 2006

Chronic Back Pain McCune-Albright Syndrome Colon Polyps

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Chronic Back Pain

If you have chronic low back pain, you may be eligible for this study of an investigational drug. Participants 21-75 must currently be taking pain medication for diagnosed chronic low back pain.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat19.html.

-----

McCune-Albright Syndrome

This study will evaluate the safety and effectiveness of the drug Faslodex (fulvestrant) to treat progressive precocious puberty (PPP) in girls with McCune-Albright Syndrome (MAS). Females younger than 11 with progressive precocious puberty associated with MAS diagnosed before the age of eight may qualify. Children will not be eligible who have had prior treatment with fulvestrant for MAS-related PPP, a history of bleeding disorders, or long-term anticoagulation therapy.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat260.html.

-----

Colon Polyps

This study will evaluate whether an ingredient of a commonly used spice called Turmeric, found in Indian curries, can alter colon cell growth. Volunteers over age 18 who do not have a history of colon cancer, Familial Polyposis Syndromes, or inflammatory bowel disease may qualify.

The research site is in Philadelphia, Penn.

More information

Please see http://www.centerwatch.com/patient/studies/cat290.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com